Published on ASSET (https://www.asset-scienceinsociety.eu)

Home > Glossary > Glossary

Glossary

A (34) | B (20) | C (59) | D (17) | E (40) | F (13) | G (26) | H (21) | I (28) | K (1) | L (8) | M (21) | N (8) | O (6) | P (42) | Q (3) | R (18) | S (53) | T (14) | U (9) | V (21) | W (3) | Z (1)
Definitionssort descending Last update
Immune 23/06/2015
Immunity 23/06/2015
Immunization 23/06/2015
Immunocompromised/ immunodeficient 23/06/2015
Impact assessment 23/06/2015
Impression management 23/06/2015
Incidence rate 23/06/2015
Incubation period 23/06/2015
Index case (or primary case) 23/06/2015
Infant mortality rate 23/06/2015
Infection 23/06/2015
Infectious disease 23/06/2015
Influenza baseline 23/06/2015
Influenza pandemic 23/06/2015
Informal communication systems 23/06/2015
Information assimetry 23/06/2015
Informed consent 23/06/2015
Innovation 23/06/2015
Integrity 23/06/2015
Intentional biological release 23/06/2015
Intentionally caused outbreak 23/06/2015
Interest group 23/06/2015
International health regulations (IHR) 23/06/2015
International travel and border controls 23/06/2015
Interoperability 23/06/2015
Interorganizational communication 23/06/2015
Interpandemic phase 23/06/2015
Isolation/ quarantine 23/06/2015

Newsletters

Select the newsletter(s) to which you want to subscribe or unsubscribe.

News from Asset project
Responsible Research and Innovation Newsletter
Asset PPRB
E-mail *

Contacts

Contacts

General inquiries: info@asset-scienceinsociety.eu

ASSET

Action plan on Science in Society related issues in Epidemics and Total pandemics
European Commission
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 612236.
Source URL: https://www.asset-scienceinsociety.eu/outputs/glossary/i